Semaglutide Weight-Loss Drug Has Superior Cardioprotective Effects in Obese Mouse Model with Heart Failure and Preserved Ejection Fraction Compared to Dietary Weight Loss

https://pubmed.ncbi.nlm.nih.gov/38094687

Semaglutide, a weight-loss drug, has cardioprotective effects exceeding those of dietary weight loss in a mouse model of obesity-related heart failure with preserved ejection fraction.